New Drug Development & Regulatory News
Bora Pharmaceuticals acquires biologics CDMO facility
Taiwan-based international contract development and manufacturing organisation (CDMO) Bora Pharmaceuticals recently announced the establishment of Bora Biologics to focus on the development of biopharmaceuticals. Read more
19 May 2022
Pharma Manufacturing News + New Drug Development & Regulatory News
SOM Biotech signs licensing agreement with the University of Minnesota
SOM Biotech, a clinical-stage biopharmaceutical company with AI-based drug discovery technology and a focus on neurological orphan diseases, announces it has signed a licensing agreement with the University of Minnesota. Read more
17 May 2022
Pharma Manufacturing News + New Drug Development & Regulatory News
CN Bio introduces PhysioMimix NASH ‘in-a-box’ reagent kit
CN Bio, a Organ-on-a-chip Company (OOC) that designs and manufactures single- and multi-organ microphysiological systems (MPS), introduced its PhysioMimix ‘in-a-box’ reagent kit for non-alcoholic steatohepatitis (NASH). Read more
10 May 2022
Pharma Manufacturing News + New Drug Development & Regulatory News
Virpax selects Kindeva as development partner for pMDI commercialisation
Virpax Pharmaceuticals, Inc. and Kindeva Drug Delivery will work together to advance the clinical program of the Virpax-developed Diclofenac topical spray film (Epoladerm) in the United States. Read more
3 May 2022
Pharma Manufacturing News + New Drug Development & Regulatory News
SciRhom starts CMC development of its first drug candidate
SciRhom GmbH announce that it has nominated the anti-iRhom2 antibody it will advance into clinical development for improved treatment of autoimmune diseases. Read more
22 Apr 2022
Pharma Manufacturing News + New Drug Development & Regulatory News
Emergex advances vaccine candidate for tularemia
Emergex Vaccines Holding is progressing preclinical development of its intracellular bacterial vaccine candidate for tularaemia, following the completion of successful ligandome generation. Read more
21 Apr 2022
Pharma Manufacturing News + New Drug Development & Regulatory News
Sponsored Content
![Rispharm green[81] copy.jpg](https://pharmaceuticalmanufacturer.media/downloads/8697/download/Rispharm%20green%5B81%5D%20copy.jpg?cb=57c84593551897ef6d3c5ef4ad4b7df0&w=640 "Rispharm green[81] copy.jpg")
Partnership introduced antimicrobial eye dropper at Pharmapack
Activated Rispharm, the multidose antimicrobial dropper to help prevent eye microbial infections for patients, was introduced at Pharmapack 2022 (18th & 19th May in Paris). Read more
20 May 2022
Editor's desk: The road to normality
Rob Anderton introduces this issue of EPM, highlighting the pharmaceutical industry's move away from the pandemic and towards a sense of normality again. Read more
11 May 2022
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
CN Bio introduces PhysioMimix NASH ‘in-a-box’ reagent kit
CN Bio, a Organ-on-a-chip Company (OOC) that designs and manufactures single- and multi-organ microphysiological systems (MPS), introduced its PhysioMimix ‘in-a-box’ reagent kit for non-alcoholic steatohepatitis (NASH). Read more
10 May 2022
Pharma Manufacturing News + New Drug Development & Regulatory News
![Rispharm green[81] copy.jpg](https://pharmaceuticalmanufacturer.media/downloads/8697/download/Rispharm%20green%5B81%5D%20copy.jpg?cb=57c84593551897ef6d3c5ef4ad4b7df0&w={width}&h={height} "Rispharm green[81] copy.jpg")
Life Science Group completes move to bigger facilities in Bedfordshire
Life Science Group (LSG) has recently completed a move to new, larger facilities in Sandy, Bedfordshire. The facilities will offer expanded manufacturing capabilities available in new cleanroom suites equipped to GMP standards. Read more
20 May 2022
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Agreement to accelerate plasmid DNA development for biopharma customers
Avantor, Inc. and Cytovance Biologics, Inc., a biologics CDMO, have entered an agreement to manufacture research and GMP grade plasmids for biopharma customers. Read more
20 May 2022
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Yseop AI software chosen by Lilly to expedite drug approval process
Yseop, an AI software company in Natural Language Processing (NLP), announced a strategic collaboration with Eli Lilly and Company, allowing Lilly to deploy Yseop’s enterprise automation platform, Augmented Analyst. Read more
20 May 2022
Pharma Manufacturing News + Pharmaceutical Logistics & Distribution News
Joint venture expands preclinical services for Japanese customers
Crown Bioscience and Medical & Biological Laboratories (MBL), JSR Life Sciences companies, announced the formation of a joint venture, to further expand the provision of Crown Bioscience’s preclinical services to Japanese customers. Read more
20 May 2022
Pharma Manufacturing News + Pharma Finance and Investment News
Bora Pharmaceuticals acquires biologics CDMO facility
Taiwan-based international contract development and manufacturing organisation (CDMO) Bora Pharmaceuticals recently announced the establishment of Bora Biologics to focus on the development of biopharmaceuticals. Read more
19 May 2022
Pharma Manufacturing News + New Drug Development & Regulatory News
Drug formulation company raises £1m investment
Aston Particle Technologies (APT) which has developed a dry powder coating technology that opens up new possibilities in pharmaceutical manufacturing has completed a £1m funding round led by DSW Ventures. Read more
18 May 2022
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Sponsored Content
White Papers
Sponsored Content
Sponsored Content
Vetter Pharma International
Vetter is a leading contract development and manufacturing organization (CDMO) that specializes in the aseptic filling of syringes, cartridges and vials. Read more
